BIOREM Inc. announced $11-million of new orders for air emission abatement projects in North America. This brought the company's order backlog to a record $40-million, its highest point since the company was founded in 1990. The new products were introduced to a carefully-selected trial market segment that accounts for approximately 1/3 of the potential North American market.

This positive initial customer response bodes well for markets outside the test area, as the company's sales network will begin marketing them to other domestic and global customers in the coming months. BIOREM's engineering and product development groups spent considerable time during the pandemic lockdowns of 2020 and 2021 designing the next generation of the company's emissions abatement equipment, supplementing the firm's traditional biological filtration products with those using the next generation of physical technologies. The new products include a consumable component that is expected to generate recurring revenues as the equipment ages and the adsorbents are consumed.

This is expected to broaden BIOREM's revenue base and growth potential as it expands its service offerings.